跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CARBOPROST TROMETHAMINE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CARBOPROST TROMETHAMINE INJECTION USP
Authorized
STANDARD
CARBOPROST TROMETHAMINE INJECTION USP
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
70efeb57551cfda3
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
70efeb57551cfda3
Drug Approval Canada Name
CARBOPROST TROMETHAMINE INJECTION USP
Product Name
CARBOPROST TROMETHAMINE INJECTION USP
Status
Marketed
Status Date
2024-01-18
Original Market Date
2024-01-18
Din
02538377
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
Prescription
Ahfs
76:00.00
Atc Original
G02AD04 CARBOPROST
Atc Name
g 02 ad 04
Aig Number
0133100001
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
CARBOPROST (CARBOPROST TROMETHAMINE)
250 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
70efeb57551cfda3
Type
Standard
Back to Health Canada Approvals